It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The O-linked β-N-acetylglucosamine modification is a core signalling mechanism, with erroneous patterns leading to cancer and neurodegeneration. Although thousands of proteins are subject to this modification, only a single essential glycosyltransferase catalyses its installation, the O-GlcNAc transferase, OGT. Previous studies have provided truncated structures of OGT through X-ray crystallography, but the full-length protein has never been observed. Here, we report a 5.3 Å cryo-EM model of OGT. We show OGT is a dimer, providing a structural basis for how some X-linked intellectual disability mutations at the interface may contribute to disease. We observe that the catalytic section of OGT abuts a 13.5 tetratricopeptide repeat unit region and find the relative positioning of these sections deviate from the previously proposed, X-ray crystallography-based model. We also note that OGT exhibits considerable heterogeneity in tetratricopeptide repeat units N-terminal to the dimer interface with repercussions for how OGT binds protein ligands and partners.
The modification of proteins with O-linked β-N-acetylglucosamine (OGlcNAc) plays roles in regulation of numerous cellular functions while incorrect O-GlcNAcylation patterns are linked to disease. Here, the authors report a cryo-EM structure of full-length O-GlcNAc transferase (OGT), the only enzyme responsible for O-GlcNAcylation.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details





1 University of York, York Structural Biology Laboratory, Department of Chemistry, York, UK (GRID:grid.5685.e) (ISNI:0000 0004 1936 9668)
2 Simon Fraser University, 8888 University Drive, Department of Molecular Biology and Biochemistry, Burnaby, Canada (GRID:grid.61971.38) (ISNI:0000 0004 1936 7494)
3 Simon Fraser University, 8888 University Drive, Department of Chemistry, Burnaby, Canada (GRID:grid.61971.38) (ISNI:0000 0004 1936 7494)
4 Simon Fraser University, 8888 University Drive, Department of Molecular Biology and Biochemistry, Burnaby, Canada (GRID:grid.61971.38) (ISNI:0000 0004 1936 7494); Simon Fraser University, 8888 University Drive, Department of Chemistry, Burnaby, Canada (GRID:grid.61971.38) (ISNI:0000 0004 1936 7494)